Key Takeaways Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Taco Bell is re-upping its value menu game with the introduction of $5, $7 and $9 luxe cravings boxes, while TikTok is ...

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

Scorpion’s drug candidate inhibits a mutation that is a major driver of breast, gynaecological and head and neck cancers ...

Elderberry juice might help people lose weight and improve their blood sugar control, a new small-scale study says.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

Top stocks for 2025 are from the companies that have proven growth track records and strong outlooks, with more potential ...

Cholesterol levels are something that many people tend to struggle with, but with the right information and lifestyle changes ...

Popflex gets a Target boost and Golden Globes give stage to weight loss drugs—plus, why it was a bad week for H&R Block, REI ...

Calling people "mentally ill" based on their sexual identity and referring to women as "household objects" will now be allowed in the context of political discussions on social media giant Meta's ...